ASP-4396
- Generic Name
- ASP-4396
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
- First Posted Date
- 2024-04-15
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 175
- Registration Number
- NCT06364696
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸University of Kansas Cancer Center, Westwood, Kansas, United States
🇺🇸START Midwest, Grand Rapids, Michigan, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath